Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Catherine Royer


Catherine Royer has joined Rensselaer Polytechnic Institute as a chair of the school's biocomputation and bioinformatics department, and as a professor in the biology department. She will begin her new roles there this month.

Royer, a molecular biophysicist, is currently director of the Center for Structural Biochemistry in Montpellier, France, a position she has held since 2007. Before that, she was a visiting director of research at the center. Her research focuses on the physical mechanisms through which biological molecules work. She is particularly interested in the mechanisms at play as DNA is transcribed into messenger RNA – with special attention to a group of transcription factors called nuclear receptors – and in the folding of proteins that have been synthesized by the ribosome.

She earned her doctorate in biochemistry at the University of Illinois, Urbana-Champaign, and received a license in biochemistry and a general academic studies degree in natural sciences from the Pierre and Marie Curie University.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.